Auto-generated challenge from hypothesis h-var-6957745fea (composite_score=0.805). Target gene: AIM2/CASP1/IL1B/PYCARD. Source hypothesis title: Mitochondrial DAMPs-Driven AIM2 Inflammasome Activation in Neurodegeneration. Success criteria: 1. mtDNA copy number in cytoplasm increases >2-fold in disease-state microglia (AD tissue or LPS model). 2. AIM2 deficiency (KO microglia) reduces caspase-1 activation by >60% vs. WT. 3. IL-1beta release decreases by >50% in AIM2-KO vs. scramble in NLRP3/ AIM2 double-stimulated cells. 4. In vivo: AIM2 inhibitor reduces microglial caspase-1 activation by >40% and improves behavioral scores.